nodes	percent_of_prediction	percent_of_DWPC	metapath
Melatonin—MTNR1B—polycystic ovary syndrome	0.485	0.68	CbGaD
Melatonin—CYP19A1—polycystic ovary syndrome	0.132	0.185	CbGaD
Melatonin—CYP1A1—polycystic ovary syndrome	0.0969	0.136	CbGaD
Melatonin—CYP19A1—follicular fluid—polycystic ovary syndrome	0.013	0.137	CbGeAlD
Melatonin—CYP19A1—corpus luteum—polycystic ovary syndrome	0.0075	0.0789	CbGeAlD
Melatonin—CYP19A1—ovarian follicle—polycystic ovary syndrome	0.00586	0.0617	CbGeAlD
Melatonin—ESR1—ovarian follicle—polycystic ovary syndrome	0.0051	0.0537	CbGeAlD
Melatonin—Gastrointestinal tract irritation—Metformin—polycystic ovary syndrome	0.00397	0.113	CcSEcCtD
Melatonin—SLC22A8—urine—polycystic ovary syndrome	0.0024	0.0253	CbGeAlD
Melatonin—CALR—embryo—polycystic ovary syndrome	0.00224	0.0235	CbGeAlD
Melatonin—Nail disorder—Metformin—polycystic ovary syndrome	0.00218	0.062	CcSEcCtD
Melatonin—ASMT—endocrine gland—polycystic ovary syndrome	0.00214	0.0225	CbGeAlD
Melatonin—CYP2C19—urine—polycystic ovary syndrome	0.00201	0.0212	CbGeAlD
Melatonin—IDO1—endocrine gland—polycystic ovary syndrome	0.00196	0.0206	CbGeAlD
Melatonin—CALR—adrenal cortex—polycystic ovary syndrome	0.00183	0.0193	CbGeAlD
Melatonin—Midodrine—ADRA1D—polycystic ovary syndrome	0.00173	0.294	CrCbGaD
Melatonin—Agomelatine—MTNR1B—polycystic ovary syndrome	0.00168	0.286	CrCbGaD
Melatonin—CYP1A2—urine—polycystic ovary syndrome	0.00164	0.0173	CbGeAlD
Melatonin—CALR—endometrium—polycystic ovary syndrome	0.00164	0.0172	CbGeAlD
Melatonin—CYP2C9—urine—polycystic ovary syndrome	0.00156	0.0164	CbGeAlD
Melatonin—CALR—uterus—polycystic ovary syndrome	0.00151	0.0159	CbGeAlD
Melatonin—CALR—pituitary gland—polycystic ovary syndrome	0.00148	0.0156	CbGeAlD
Melatonin—Midodrine—ADRA1B—polycystic ovary syndrome	0.00148	0.251	CrCbGaD
Melatonin—CALR—adipose tissue—polycystic ovary syndrome	0.00147	0.0155	CbGeAlD
Melatonin—MT3—endocrine gland—polycystic ovary syndrome	0.00145	0.0153	CbGeAlD
Melatonin—CALR—adrenal gland—polycystic ovary syndrome	0.00132	0.0139	CbGeAlD
Melatonin—CALR—female gonad—polycystic ovary syndrome	0.00123	0.013	CbGeAlD
Melatonin—CALR—vagina—polycystic ovary syndrome	0.00123	0.0129	CbGeAlD
Melatonin—CALR—endocrine gland—polycystic ovary syndrome	0.00115	0.0121	CbGeAlD
Melatonin—Lethargy—Metformin—polycystic ovary syndrome	0.00105	0.0298	CcSEcCtD
Melatonin—NQO2—adrenal cortex—polycystic ovary syndrome	0.00103	0.0109	CbGeAlD
Melatonin—Pain in extremity—Metformin—polycystic ovary syndrome	0.00103	0.0292	CcSEcCtD
Melatonin—Migraine—Metformin—polycystic ovary syndrome	0.00101	0.0287	CcSEcCtD
Melatonin—Midodrine—ADRA1A—polycystic ovary syndrome	0.000996	0.169	CrCbGaD
Melatonin—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.000949	0.027	CcSEcCtD
Melatonin—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.000939	0.0267	CcSEcCtD
Melatonin—Breast disorder—Metformin—polycystic ovary syndrome	0.000929	0.0264	CcSEcCtD
Melatonin—NQO2—endometrium—polycystic ovary syndrome	0.000923	0.00971	CbGeAlD
Melatonin—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.000919	0.0261	CcSEcCtD
Melatonin—Angina pectoris—Metformin—polycystic ovary syndrome	0.000866	0.0246	CcSEcCtD
Melatonin—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.000852	0.0242	CcSEcCtD
Melatonin—NQO2—uterus—polycystic ovary syndrome	0.00085	0.00895	CbGeAlD
Melatonin—NQO2—pituitary gland—polycystic ovary syndrome	0.000835	0.00879	CbGeAlD
Melatonin—NQO2—adipose tissue—polycystic ovary syndrome	0.000832	0.00875	CbGeAlD
Melatonin—Infestation NOS—Metformin—polycystic ovary syndrome	0.000792	0.0225	CcSEcCtD
Melatonin—Infestation—Metformin—polycystic ovary syndrome	0.000792	0.0225	CcSEcCtD
Melatonin—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.000749	0.0213	CcSEcCtD
Melatonin—NQO2—adrenal gland—polycystic ovary syndrome	0.000746	0.00785	CbGeAlD
Melatonin—CALM3—adrenal cortex—polycystic ovary syndrome	0.000715	0.00753	CbGeAlD
Melatonin—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.000699	0.0199	CcSEcCtD
Melatonin—NQO2—female gonad—polycystic ovary syndrome	0.000696	0.00732	CbGeAlD
Melatonin—NQO2—vagina—polycystic ovary syndrome	0.000691	0.00728	CbGeAlD
Melatonin—ESR1—embryo—polycystic ovary syndrome	0.000689	0.00726	CbGeAlD
Melatonin—CALM2—embryo—polycystic ovary syndrome	0.000685	0.00721	CbGeAlD
Melatonin—CALM1—embryo—polycystic ovary syndrome	0.000682	0.00718	CbGeAlD
Melatonin—Eye disorder—Metformin—polycystic ovary syndrome	0.000665	0.0189	CcSEcCtD
Melatonin—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00066	0.0188	CcSEcCtD
Melatonin—NQO2—endocrine gland—polycystic ovary syndrome	0.000647	0.00681	CbGeAlD
Melatonin—Angiopathy—Metformin—polycystic ovary syndrome	0.000645	0.0183	CcSEcCtD
Melatonin—MPO—pituitary gland—polycystic ovary syndrome	0.000643	0.00677	CbGeAlD
Melatonin—Immune system disorder—Metformin—polycystic ovary syndrome	0.000642	0.0183	CcSEcCtD
Melatonin—CALM3—endometrium—polycystic ovary syndrome	0.000638	0.00672	CbGeAlD
Melatonin—Erythema—Metformin—polycystic ovary syndrome	0.000619	0.0176	CcSEcCtD
Melatonin—Malnutrition—Metformin—polycystic ovary syndrome	0.000619	0.0176	CcSEcCtD
Melatonin—Flatulence—Metformin—polycystic ovary syndrome	0.00061	0.0173	CcSEcCtD
Melatonin—Muscle spasms—Metformin—polycystic ovary syndrome	0.000595	0.0169	CcSEcCtD
Melatonin—CALM3—uterus—polycystic ovary syndrome	0.000588	0.00619	CbGeAlD
Melatonin—Vision blurred—Metformin—polycystic ovary syndrome	0.000583	0.0166	CcSEcCtD
Melatonin—CYP19A1—endometrium—polycystic ovary syndrome	0.00058	0.00611	CbGeAlD
Melatonin—CALM3—pituitary gland—polycystic ovary syndrome	0.000578	0.00608	CbGeAlD
Melatonin—CALM3—adipose tissue—polycystic ovary syndrome	0.000575	0.00606	CbGeAlD
Melatonin—MPO—adrenal gland—polycystic ovary syndrome	0.000574	0.00604	CbGeAlD
Melatonin—CALM2—adrenal cortex—polycystic ovary syndrome	0.000561	0.00591	CbGeAlD
Melatonin—CALM1—adrenal cortex—polycystic ovary syndrome	0.000559	0.00588	CbGeAlD
Melatonin—Syncope—Metformin—polycystic ovary syndrome	0.000555	0.0158	CcSEcCtD
Melatonin—Palpitations—Metformin—polycystic ovary syndrome	0.000547	0.0155	CcSEcCtD
Melatonin—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000544	0.0155	CcSEcCtD
Melatonin—CYP19A1—uterus—polycystic ovary syndrome	0.000535	0.00563	CbGeAlD
Melatonin—Hypertension—Metformin—polycystic ovary syndrome	0.000535	0.0152	CcSEcCtD
Melatonin—Chest pain—Metformin—polycystic ovary syndrome	0.000527	0.015	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000523	0.0149	CcSEcCtD
Melatonin—CYP19A1—adipose tissue—polycystic ovary syndrome	0.000523	0.00551	CbGeAlD
Melatonin—CALM3—adrenal gland—polycystic ovary syndrome	0.000516	0.00543	CbGeAlD
Melatonin—ESR1—endometrium—polycystic ovary syndrome	0.000504	0.00531	CbGeAlD
Melatonin—Infection—Metformin—polycystic ovary syndrome	0.000502	0.0143	CcSEcCtD
Melatonin—CALM2—endometrium—polycystic ovary syndrome	0.000501	0.00528	CbGeAlD
Melatonin—CYP1B1—uterus—polycystic ovary syndrome	0.0005	0.00526	CbGeAlD
Melatonin—CALM1—endometrium—polycystic ovary syndrome	0.000499	0.00525	CbGeAlD
Melatonin—MPO—endocrine gland—polycystic ovary syndrome	0.000498	0.00524	CbGeAlD
Melatonin—Shock—Metformin—polycystic ovary syndrome	0.000497	0.0141	CcSEcCtD
Melatonin—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000496	0.0141	CcSEcCtD
Melatonin—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000495	0.0141	CcSEcCtD
Melatonin—CYP1B1—pituitary gland—polycystic ovary syndrome	0.000491	0.00517	CbGeAlD
Melatonin—Skin disorder—Metformin—polycystic ovary syndrome	0.000491	0.0139	CcSEcCtD
Melatonin—CYP1B1—adipose tissue—polycystic ovary syndrome	0.000489	0.00515	CbGeAlD
Melatonin—CALM3—female gonad—polycystic ovary syndrome	0.000481	0.00507	CbGeAlD
Melatonin—CALM3—vagina—polycystic ovary syndrome	0.000478	0.00503	CbGeAlD
Melatonin—CYP19A1—adrenal gland—polycystic ovary syndrome	0.000469	0.00494	CbGeAlD
Melatonin—ESR1—uterus—polycystic ovary syndrome	0.000465	0.00489	CbGeAlD
Melatonin—CALM2—uterus—polycystic ovary syndrome	0.000462	0.00486	CbGeAlD
Melatonin—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00046	0.0131	CcSEcCtD
Melatonin—CALM1—uterus—polycystic ovary syndrome	0.00046	0.00484	CbGeAlD
Melatonin—ESR1—pituitary gland—polycystic ovary syndrome	0.000456	0.0048	CbGeAlD
Melatonin—ESR1—adipose tissue—polycystic ovary syndrome	0.000455	0.00478	CbGeAlD
Melatonin—Paraesthesia—Metformin—polycystic ovary syndrome	0.000454	0.0129	CcSEcCtD
Melatonin—CALM2—pituitary gland—polycystic ovary syndrome	0.000454	0.00478	CbGeAlD
Melatonin—CALM2—adipose tissue—polycystic ovary syndrome	0.000452	0.00476	CbGeAlD
Melatonin—CALM1—pituitary gland—polycystic ovary syndrome	0.000452	0.00475	CbGeAlD
Melatonin—CALM1—adipose tissue—polycystic ovary syndrome	0.00045	0.00473	CbGeAlD
Melatonin—Somnolence—Metformin—polycystic ovary syndrome	0.000449	0.0128	CcSEcCtD
Melatonin—Dyspepsia—Metformin—polycystic ovary syndrome	0.000445	0.0126	CcSEcCtD
Melatonin—CYP1B1—adrenal gland—polycystic ovary syndrome	0.000439	0.00462	CbGeAlD
Melatonin—CYP19A1—female gonad—polycystic ovary syndrome	0.000437	0.0046	CbGeAlD
Melatonin—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000436	0.0124	CcSEcCtD
Melatonin—Fatigue—Metformin—polycystic ovary syndrome	0.000436	0.0124	CcSEcCtD
Melatonin—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000413	0.0117	CcSEcCtD
Melatonin—CYP1B1—female gonad—polycystic ovary syndrome	0.000409	0.0043	CbGeAlD
Melatonin—ESR1—adrenal gland—polycystic ovary syndrome	0.000408	0.00429	CbGeAlD
Melatonin—CYP19A1—endocrine gland—polycystic ovary syndrome	0.000407	0.00428	CbGeAlD
Melatonin—CALM2—adrenal gland—polycystic ovary syndrome	0.000405	0.00427	CbGeAlD
Melatonin—CALM1—adrenal gland—polycystic ovary syndrome	0.000403	0.00425	CbGeAlD
Melatonin—Abdominal pain—Metformin—polycystic ovary syndrome	0.000399	0.0113	CcSEcCtD
Melatonin—CYP1B1—endocrine gland—polycystic ovary syndrome	0.00038	0.004	CbGeAlD
Melatonin—ESR1—female gonad—polycystic ovary syndrome	0.00038	0.004	CbGeAlD
Melatonin—CALM2—female gonad—polycystic ovary syndrome	0.000378	0.00398	CbGeAlD
Melatonin—ESR1—vagina—polycystic ovary syndrome	0.000378	0.00398	CbGeAlD
Melatonin—CALM1—female gonad—polycystic ovary syndrome	0.000376	0.00396	CbGeAlD
Melatonin—CALM2—vagina—polycystic ovary syndrome	0.000376	0.00395	CbGeAlD
Melatonin—CALM1—vagina—polycystic ovary syndrome	0.000374	0.00394	CbGeAlD
Melatonin—Asthenia—Metformin—polycystic ovary syndrome	0.000363	0.0103	CcSEcCtD
Melatonin—Pruritus—Metformin—polycystic ovary syndrome	0.000357	0.0102	CcSEcCtD
Melatonin—CYP2C19—vagina—polycystic ovary syndrome	0.000357	0.00375	CbGeAlD
Melatonin—ESR1—endocrine gland—polycystic ovary syndrome	0.000354	0.00372	CbGeAlD
Melatonin—CYP1A1—uterus—polycystic ovary syndrome	0.000353	0.00372	CbGeAlD
Melatonin—CALM2—endocrine gland—polycystic ovary syndrome	0.000351	0.0037	CbGeAlD
Melatonin—CALM1—endocrine gland—polycystic ovary syndrome	0.00035	0.00368	CbGeAlD
Melatonin—CYP1A1—adipose tissue—polycystic ovary syndrome	0.000346	0.00364	CbGeAlD
Melatonin—Dizziness—Metformin—polycystic ovary syndrome	0.000334	0.00949	CcSEcCtD
Melatonin—CYP2C19—endocrine gland—polycystic ovary syndrome	0.000334	0.00351	CbGeAlD
Melatonin—Vomiting—Metformin—polycystic ovary syndrome	0.000321	0.00913	CcSEcCtD
Melatonin—Rash—Metformin—polycystic ovary syndrome	0.000319	0.00905	CcSEcCtD
Melatonin—Dermatitis—Metformin—polycystic ovary syndrome	0.000318	0.00904	CcSEcCtD
Melatonin—Headache—Metformin—polycystic ovary syndrome	0.000317	0.00899	CcSEcCtD
Melatonin—Nausea—Metformin—polycystic ovary syndrome	0.0003	0.00853	CcSEcCtD
Melatonin—CYP1A1—female gonad—polycystic ovary syndrome	0.000289	0.00304	CbGeAlD
Melatonin—CYP1A1—vagina—polycystic ovary syndrome	0.000287	0.00302	CbGeAlD
Melatonin—CYP1A2—endocrine gland—polycystic ovary syndrome	0.000273	0.00287	CbGeAlD
Melatonin—CYP1A1—endocrine gland—polycystic ovary syndrome	0.000269	0.00283	CbGeAlD
Melatonin—CYP2C9—endocrine gland—polycystic ovary syndrome	0.000259	0.00272	CbGeAlD
Melatonin—CALM3—Signaling Pathways—AKR1C3—polycystic ovary syndrome	5.3e-06	3.52e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—GNAS—polycystic ovary syndrome	5.28e-06	3.51e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	5.28e-06	3.51e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—IL18—polycystic ovary syndrome	5.27e-06	3.5e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—IL18—polycystic ovary syndrome	5.27e-06	3.5e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	5.26e-06	3.5e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—SLC2A4—polycystic ovary syndrome	5.25e-06	3.49e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	5.25e-06	3.49e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—TH—polycystic ovary syndrome	5.22e-06	3.47e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—TH—polycystic ovary syndrome	5.22e-06	3.47e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	5.22e-06	3.47e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	5.21e-06	3.46e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	5.2e-06	3.45e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	5.18e-06	3.44e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PGR—polycystic ovary syndrome	5.17e-06	3.43e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—NRG1—polycystic ovary syndrome	5.16e-06	3.43e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—NRG1—polycystic ovary syndrome	5.16e-06	3.43e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	5.14e-06	3.42e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	5.13e-06	3.41e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	5.13e-06	3.41e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—TH—polycystic ovary syndrome	5.12e-06	3.4e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—SLC2A4—polycystic ovary syndrome	5.08e-06	3.38e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—SLC2A4—polycystic ovary syndrome	5.08e-06	3.38e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	5.05e-06	3.35e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	5.05e-06	3.35e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.03e-06	3.34e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by NGF—IL6—polycystic ovary syndrome	5.02e-06	3.34e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—NCOR1—polycystic ovary syndrome	5.01e-06	3.33e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	5.01e-06	3.33e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PGR—polycystic ovary syndrome	5e-06	3.32e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PGR—polycystic ovary syndrome	5e-06	3.32e-05	CbGpPWpGaD
Melatonin—ESR1—Gene Expression—SERPINE1—polycystic ovary syndrome	4.99e-06	3.32e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—SLC2A4—polycystic ovary syndrome	4.98e-06	3.31e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	4.98e-06	3.31e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—CYP19A1—polycystic ovary syndrome	4.94e-06	3.28e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—NRG1—polycystic ovary syndrome	4.94e-06	3.28e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	4.92e-06	3.27e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—NRG1—polycystic ovary syndrome	4.92e-06	3.27e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by NGF—IL6—polycystic ovary syndrome	4.86e-06	3.23e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by NGF—IL6—polycystic ovary syndrome	4.86e-06	3.23e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—NCOR1—polycystic ovary syndrome	4.85e-06	3.22e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—NCOR1—polycystic ovary syndrome	4.85e-06	3.22e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	4.85e-06	3.22e-05	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—PPARG—polycystic ovary syndrome	4.82e-06	3.2e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	4.81e-06	3.2e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—GHRL—polycystic ovary syndrome	4.8e-06	3.19e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PLAT—polycystic ovary syndrome	4.8e-06	3.19e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	4.78e-06	3.18e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—CYP19A1—polycystic ovary syndrome	4.78e-06	3.17e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—CYP19A1—polycystic ovary syndrome	4.78e-06	3.17e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—NRG1—polycystic ovary syndrome	4.76e-06	3.16e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—NRG1—polycystic ovary syndrome	4.76e-06	3.16e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	4.75e-06	3.16e-05	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—POMC—polycystic ovary syndrome	4.75e-06	3.15e-05	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—INS—polycystic ovary syndrome	4.72e-06	3.14e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	4.72e-06	3.13e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—CYP19A1—polycystic ovary syndrome	4.69e-06	3.11e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PLAT—polycystic ovary syndrome	4.65e-06	3.09e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—GHRL—polycystic ovary syndrome	4.65e-06	3.09e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PLAT—polycystic ovary syndrome	4.65e-06	3.09e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—GHRL—polycystic ovary syndrome	4.65e-06	3.09e-05	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—PPARG—polycystic ovary syndrome	4.64e-06	3.08e-05	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—VEGFA—polycystic ovary syndrome	4.6e-06	3.06e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	4.59e-06	3.05e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—ATF1—polycystic ovary syndrome	4.58e-06	3.04e-05	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—POMC—polycystic ovary syndrome	4.57e-06	3.04e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—IRS2—polycystic ovary syndrome	4.57e-06	3.03e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—CRP—polycystic ovary syndrome	4.57e-06	3.03e-05	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—INS—polycystic ovary syndrome	4.55e-06	3.02e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	4.49e-06	2.98e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	4.47e-06	2.97e-05	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—VEGFA—polycystic ovary syndrome	4.45e-06	2.96e-05	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—VEGFA—polycystic ovary syndrome	4.45e-06	2.96e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	4.44e-06	2.95e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—ATF1—polycystic ovary syndrome	4.43e-06	2.94e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—ATF1—polycystic ovary syndrome	4.43e-06	2.94e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—MTHFR—polycystic ovary syndrome	4.43e-06	2.94e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	4.42e-06	2.93e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—IRS2—polycystic ovary syndrome	4.42e-06	2.93e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—IRS2—polycystic ovary syndrome	4.42e-06	2.93e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—CRP—polycystic ovary syndrome	4.42e-06	2.93e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—CRP—polycystic ovary syndrome	4.42e-06	2.93e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—GNAS—polycystic ovary syndrome	4.41e-06	2.93e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	4.32e-06	2.87e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	4.32e-06	2.87e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—MTHFR—polycystic ovary syndrome	4.29e-06	2.85e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—MTHFR—polycystic ovary syndrome	4.29e-06	2.85e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	4.28e-06	2.84e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—GNAS—polycystic ovary syndrome	4.26e-06	2.83e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—GNAS—polycystic ovary syndrome	4.26e-06	2.83e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—IRS2—polycystic ovary syndrome	4.23e-06	2.81e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—NGFR—polycystic ovary syndrome	4.23e-06	2.81e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—IRS2—polycystic ovary syndrome	4.22e-06	2.8e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—POMC—polycystic ovary syndrome	4.2e-06	2.79e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—NCOR1—polycystic ovary syndrome	4.2e-06	2.79e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—TH—polycystic ovary syndrome	4.19e-06	2.78e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PRL—polycystic ovary syndrome	4.19e-06	2.78e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—GNAS—polycystic ovary syndrome	4.18e-06	2.78e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—LEP—polycystic ovary syndrome	4.14e-06	2.75e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	4.11e-06	2.73e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—NGFR—polycystic ovary syndrome	4.09e-06	2.72e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—NGFR—polycystic ovary syndrome	4.09e-06	2.72e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	4.09e-06	2.72e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	4.08e-06	2.71e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—IRS2—polycystic ovary syndrome	4.08e-06	2.71e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—IRS2—polycystic ovary syndrome	4.08e-06	2.71e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—POMC—polycystic ovary syndrome	4.06e-06	2.7e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—POMC—polycystic ovary syndrome	4.06e-06	2.7e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—NCOR1—polycystic ovary syndrome	4.06e-06	2.7e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—NCOR1—polycystic ovary syndrome	4.06e-06	2.7e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	4.06e-06	2.7e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PRL—polycystic ovary syndrome	4.05e-06	2.69e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PRL—polycystic ovary syndrome	4.05e-06	2.69e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—AKT2—polycystic ovary syndrome	4.04e-06	2.68e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	4.03e-06	2.68e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—IRS1—polycystic ovary syndrome	3.99e-06	2.65e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—NCOR1—polycystic ovary syndrome	3.98e-06	2.65e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—CYP1A1—polycystic ovary syndrome	3.98e-06	2.64e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—ADRB2—polycystic ovary syndrome	3.98e-06	2.64e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—AKT2—polycystic ovary syndrome	3.91e-06	2.59e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	3.91e-06	2.59e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—IRS1—polycystic ovary syndrome	3.86e-06	2.56e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—IRS1—polycystic ovary syndrome	3.86e-06	2.56e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—CYP1A1—polycystic ovary syndrome	3.85e-06	2.56e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—CYP1A1—polycystic ovary syndrome	3.85e-06	2.56e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—ADRB2—polycystic ovary syndrome	3.85e-06	2.55e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	3.85e-06	2.55e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	3.84e-06	2.55e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	3.84e-06	2.55e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—TH—polycystic ovary syndrome	3.82e-06	2.54e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	3.78e-06	2.51e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	3.72e-06	2.47e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—MTHFR—polycystic ovary syndrome	3.71e-06	2.47e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—IRS1—polycystic ovary syndrome	3.69e-06	2.45e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—AKT2—polycystic ovary syndrome	3.69e-06	2.45e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—GNAS—polycystic ovary syndrome	3.69e-06	2.45e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—IRS1—polycystic ovary syndrome	3.68e-06	2.44e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—MTHFR—polycystic ovary syndrome	3.59e-06	2.38e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—MTHFR—polycystic ovary syndrome	3.59e-06	2.38e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—AKT2—polycystic ovary syndrome	3.57e-06	2.37e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—AKT2—polycystic ovary syndrome	3.57e-06	2.37e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—GNAS—polycystic ovary syndrome	3.57e-06	2.37e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—GNAS—polycystic ovary syndrome	3.57e-06	2.37e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—IRS1—polycystic ovary syndrome	3.56e-06	2.36e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—IRS1—polycystic ovary syndrome	3.56e-06	2.36e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—POMC—polycystic ovary syndrome	3.56e-06	2.36e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—INS—polycystic ovary syndrome	3.54e-06	2.35e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—INS—polycystic ovary syndrome	3.52e-06	2.34e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—MTHFR—polycystic ovary syndrome	3.52e-06	2.34e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—NCOR1—polycystic ovary syndrome	3.51e-06	2.33e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	3.5e-06	2.32e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—NRG1—polycystic ovary syndrome	3.45e-06	2.29e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	3.42e-06	2.27e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—IGF1—polycystic ovary syndrome	3.42e-06	2.27e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—AKT2—polycystic ovary syndrome	3.42e-06	2.27e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—INS—polycystic ovary syndrome	3.41e-06	2.26e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—INS—polycystic ovary syndrome	3.41e-06	2.26e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—AKT2—polycystic ovary syndrome	3.41e-06	2.26e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	3.4e-06	2.26e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	3.4e-06	2.26e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—NRG1—polycystic ovary syndrome	3.33e-06	2.21e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—NRG1—polycystic ovary syndrome	3.33e-06	2.21e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—AKT2—polycystic ovary syndrome	3.3e-06	2.19e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—AKT2—polycystic ovary syndrome	3.3e-06	2.19e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—TH—polycystic ovary syndrome	3.27e-06	2.17e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	3.26e-06	2.17e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.25e-06	2.16e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—SERPINE1—polycystic ovary syndrome	3.24e-06	2.15e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—BCL2—polycystic ovary syndrome	3.22e-06	2.14e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	3.18e-06	2.11e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—SERPINE1—polycystic ovary syndrome	3.13e-06	2.08e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—SERPINE1—polycystic ovary syndrome	3.13e-06	2.08e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	3.12e-06	2.07e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—BCL2—polycystic ovary syndrome	3.12e-06	2.07e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—BCL2—polycystic ovary syndrome	3.12e-06	2.07e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	3.09e-06	2.05e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PPARG—polycystic ovary syndrome	3.01e-06	2e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	2.99e-06	1.98e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	2.97e-06	1.97e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—POMC—polycystic ovary syndrome	2.97e-06	1.97e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IRS2—polycystic ovary syndrome	2.95e-06	1.96e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—INS—polycystic ovary syndrome	2.95e-06	1.96e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PPARG—polycystic ovary syndrome	2.91e-06	1.93e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PPARG—polycystic ovary syndrome	2.91e-06	1.93e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—LEP—polycystic ovary syndrome	2.89e-06	1.92e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	2.88e-06	1.91e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—POMC—polycystic ovary syndrome	2.87e-06	1.91e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—POMC—polycystic ovary syndrome	2.87e-06	1.91e-05	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—IL6—polycystic ovary syndrome	2.86e-06	1.9e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IRS2—polycystic ovary syndrome	2.86e-06	1.9e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IRS2—polycystic ovary syndrome	2.86e-06	1.9e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PPARG—polycystic ovary syndrome	2.86e-06	1.9e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—INS—polycystic ovary syndrome	2.86e-06	1.9e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—INS—polycystic ovary syndrome	2.86e-06	1.9e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	2.82e-06	1.87e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—POMC—polycystic ovary syndrome	2.82e-06	1.87e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—INS—polycystic ovary syndrome	2.8e-06	1.86e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—LEP—polycystic ovary syndrome	2.79e-06	1.86e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—LEP—polycystic ovary syndrome	2.79e-06	1.86e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—IL6—polycystic ovary syndrome	2.77e-06	1.84e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—IL6—polycystic ovary syndrome	2.77e-06	1.84e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	2.67e-06	1.77e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	2.63e-06	1.75e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IRS1—polycystic ovary syndrome	2.58e-06	1.71e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	2.54e-06	1.69e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IRS1—polycystic ovary syndrome	2.49e-06	1.66e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IRS1—polycystic ovary syndrome	2.49e-06	1.66e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—POMC—polycystic ovary syndrome	2.48e-06	1.65e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—INS—polycystic ovary syndrome	2.47e-06	1.64e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	2.41e-06	1.6e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—POMC—polycystic ovary syndrome	2.4e-06	1.59e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—POMC—polycystic ovary syndrome	2.4e-06	1.59e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—INS—polycystic ovary syndrome	2.39e-06	1.59e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—INS—polycystic ovary syndrome	2.39e-06	1.59e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IGF1—polycystic ovary syndrome	2.39e-06	1.59e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—AKT2—polycystic ovary syndrome	2.39e-06	1.58e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	2.34e-06	1.55e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IGF1—polycystic ovary syndrome	2.31e-06	1.53e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IGF1—polycystic ovary syndrome	2.31e-06	1.53e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—AKT2—polycystic ovary syndrome	2.31e-06	1.53e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—AKT2—polycystic ovary syndrome	2.31e-06	1.53e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	2.3e-06	1.53e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—INS—polycystic ovary syndrome	2.29e-06	1.52e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.27e-06	1.51e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	2.25e-06	1.49e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.23e-06	1.48e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.19e-06	1.46e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.19e-06	1.46e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	2.13e-06	1.42e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	2.1e-06	1.4e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—INS—polycystic ovary syndrome	2.09e-06	1.39e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—IL6—polycystic ovary syndrome	1.83e-06	1.21e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	1.82e-06	1.21e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	1.8e-06	1.19e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—INS—polycystic ovary syndrome	1.79e-06	1.19e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—IL6—polycystic ovary syndrome	1.77e-06	1.17e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—IL6—polycystic ovary syndrome	1.77e-06	1.17e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—IL6—polycystic ovary syndrome	1.67e-06	1.11e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—IL6—polycystic ovary syndrome	1.61e-06	1.07e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—IL6—polycystic ovary syndrome	1.61e-06	1.07e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.56e-06	1.04e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—IL6—polycystic ovary syndrome	1.54e-06	1.03e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—IL6—polycystic ovary syndrome	1.54e-06	1.02e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.51e-06	1e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.51e-06	1e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—IL6—polycystic ovary syndrome	1.49e-06	9.9e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—IL6—polycystic ovary syndrome	1.49e-06	9.9e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IL6—polycystic ovary syndrome	1.08e-06	7.16e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IL6—polycystic ovary syndrome	1.04e-06	6.93e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IL6—polycystic ovary syndrome	1.04e-06	6.93e-06	CbGpPWpGaD
